Study at a glance
What is hypercalcaemia, and how does vitamin D relate to it?
Hypercalcaemia means too much calcium in the blood. Excess vitamin D activity can cause it, but high calcium also has other causes. The cause needs to be established rather than assumed from supplement use alone.
Does a high vitamin D blood result prove toxicity?
No. Clinicians consider the result alongside calcium, symptoms, kidney function and the type and amount of vitamin D exposure. A high result is still a reason for assessment, even when the person feels well.
Why can high calcium occur without an extremely high routine vitamin D result?
Some conditions make too much active vitamin D or reduce its breakdown. Active-vitamin-D medicines can also act beyond the step measured by the usual status test.
Which problems can vitamin D-related high calcium cause?
It can cause thirst, frequent urination, nausea, weakness, confusion and dehydration, and can harm the kidneys. These symptoms are not specific to vitamin D, so the laboratory and clinical picture must be considered together.
Read the full article below ↓Vitamin D toxicity and hypercalcaemia are closely related, but they are not interchangeable terms. A very high vitamin D concentration can raise concern about excessive exposure, yet the clinically important toxicity problem is excessive vitamin D-mediated calcium activity. Conversely, hypercalcaemia caused through vitamin D pathways does not always arise from massive vitamin D supplementation. Excessive active-hormone production, impaired vitamin D degradation and particular disease states can disturb calcium regulation through mechanisms that produce different laboratory patterns. The most useful interpretation therefore starts with physiology: what is happening to calcium, what is driving vitamin D activity, and whether the biochemical pattern fits the suspected mechanism.
Why hypercalcaemia sits at the centre of vitamin D toxicity
Vitamin D normally supports calcium homeostasis by increasing intestinal calcium absorption and participating in the hormonal regulation of calcium, phosphate, bone and kidney function. Those normal actions explain why excessive vitamin D activity can become harmful. If calcium absorption and vitamin D-mediated mineral activity exceed the body’s capacity to compensate, urinary calcium can rise and sustained hypercalcaemia can develop.
The wider regulatory background is described in Vitamin D and Calcium Physiology. As serum calcium rises, parathyroid hormone (PTH) is normally suppressed. The kidney can increase calcium excretion, providing an important compensatory route. This means that hypercalciuria can occur before, alongside or sometimes without severe sustained hypercalcaemia.
A high vitamin D result is not the same thing as toxicity
Serum 25-hydroxyvitamin D [25(OH)D] is the principal circulating marker used to assess vitamin D status and is also important when excessive vitamin D₂ or vitamin D₃ intake is suspected. In classical exogenous intoxication, 25(OH)D can become extremely high. But the concentration alone does not establish the complete clinical state.
People vary in the calcium response associated with high vitamin D concentrations, and there is no single 25(OH)D value at which every person necessarily becomes hypercalcaemic. This is why the distinction developed in Vitamin D Thresholds vs Targets remains relevant at the upper end of the range. A numerical boundary can identify increasing concern without becoming a universal biological switch.
Classical toxicity usually begins with excessive exposure
The familiar form of vitamin D toxicity follows excessive and usually sustained exposure to vitamin D₂ or vitamin D₃. Published cases commonly involve very large doses, dosing mistakes, inappropriate continuation of pharmacological regimens or products containing substantially more vitamin D than expected.
At sufficiently high exposure, normal vitamin D metabolism and binding no longer prevent excessive biological activity. Intestinal calcium absorption increases, PTH falls, urinary calcium may rise and hypercalcaemia can become clinically important. Symptoms associated with severe toxicity largely reflect the effects of hypercalcaemia, including thirst, frequent urination, nausea, weakness, confusion and dehydration.
Vitamin D-mediated hypercalcaemia can occur without massive supplementation
Some disorders reach the same calcium endpoint from a different starting point. In granulomatous diseases such as sarcoidosis or tuberculosis, activated macrophages can express CYP27B1 and convert 25(OH)D into the active hormone 1,25-dihydroxyvitamin D [1,25(OH)₂D]. Some lymphomas can produce a similar calcitriol-mediated pattern.
This mechanism differs fundamentally from ordinary vitamin D overdose. The problem is excessive active-hormone production outside the normal renal endocrine control system. A patient can therefore develop vitamin D-mediated hypercalcaemia without the extreme 25(OH)D concentration expected after massive vitamin D₂ or vitamin D₃ exposure.
Failure of vitamin D clearance creates another route
CYP24A1 normally helps limit vitamin D activity by metabolising 25(OH)D and 1,25(OH)₂D. Severe loss of CYP24A1 function therefore creates a clearance defect. Vitamin D metabolites can persist for longer than they should, producing excessive calcium activity even when excessive supplementation is not the initiating problem.
This is why Vitamin D Clearance and Degradation belongs directly within the toxicity picture. Excessive biological activity can arise because too much substrate enters the pathway, because excessive active hormone is produced, or because normal metabolic removal fails.
CYP24A1-related disease can produce hypercalcaemia, hypercalciuria, nephrocalcinosis and kidney stones, often with suppressed PTH. The metabolic pattern may also include unusually low formation of 24,25-dihydroxyvitamin D relative to available 25(OH)D, helping distinguish impaired degradation from ordinary excessive intake.
The same calcium result can therefore have different meanings
Hypercalcaemia is a downstream phenotype rather than a diagnosis of mechanism. Massive vitamin D intake can raise 25(OH)D to supraphysiological concentrations. Granulomatous disease or lymphoma can generate excessive 1,25(OH)₂D. CYP24A1 deficiency can prolong exposure to vitamin D metabolites because catabolism is impaired. Direct calcitriol or active-vitamin-D treatment can drive receptor activity downstream of the normal status marker.
These mechanisms can all suppress PTH and increase calcium exposure, but their metabolite patterns, exposure histories and clinical implications differ. Calling every one of them simply “vitamin D overdose” removes information that is necessary for correct interpretation.
Why kidney physiology matters
The kidney is important both before and after calcium dysregulation develops. It is a major site of regulated calcitriol production and vitamin D metabolism, and it also provides a route for eliminating excess calcium. When calcium absorption increases, greater urinary calcium excretion can initially help stabilise serum calcium.
That compensation can itself become clinically significant. Persistent hypercalciuria can promote nephrolithiasis and nephrocalcinosis, while severe hypercalcaemia can impair renal concentrating ability, contribute to dehydration and worsen renal function. The broader organ relationship is developed in Vitamin D and Kidneys.
PTH helps place the calcium abnormality in context
When vitamin D-mediated calcium activity drives serum calcium upward, PTH should normally fall. Suppressed PTH is therefore an important part of the physiological pattern. Hypercalcaemia with PTH that is not appropriately suppressed points toward a different regulatory problem and prevents vitamin D supplementation from being blamed automatically simply because it appears on a medication list.
This is an important clinical distinction because hypercalcaemia has causes unrelated to vitamin D. Exposure history, calcium, PTH, renal function and the relevant vitamin D metabolites need to agree sufficiently before a vitamin D-mediated explanation becomes convincing.
Why one vitamin D measurement cannot answer every toxicity question
25(OH)D is highly informative in suspected classical vitamin D₂ or vitamin D₃ intoxication, but it is not a direct measurement of every route to excessive vitamin D activity. In granulomatous disease, the critical abnormality may be excessive conversion to 1,25(OH)₂D. In CYP24A1 deficiency, metabolite degradation and metabolite ratios can carry important information. With direct active-vitamin-D treatment, biological activity can be excessive downstream of the usual nutritional-status marker.
The correct conclusion is not that vitamin D blood tests are unhelpful. It is that the measured metabolite must be matched to the physiological question being asked.
The practical distinction
Vitamin D toxicity is best understood as harmful excessive vitamin D activity, usually recognised through disturbed calcium physiology, rather than as a synonym for any high vitamin D concentration. Classical excessive intake remains an important and well-established cause, but it sits alongside other vitamin D-mediated hypercalcaemic mechanisms involving excessive active-hormone production and defective clearance.
The strongest interpretation therefore keeps four questions separate: how much vitamin D exposure occurred, which metabolite or pathway is abnormal, whether calcium regulation is disturbed, and what physiological mechanism explains the pattern. That framework preserves the usefulness of vitamin D concentrations without asking one number to describe the entire system.
Scientific sources and publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521 to 547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity-A Clinical Perspective. Frontiers in Endocrinology. 2018;9:550. PMID: 30294301. PMCID: PMC6158375. DOI: 10.3389/fendo.2018.00550.
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13 to 31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.
Related reading
10 years of 25-hydroxyvitamin-D testing by LC-MS/MS-trends in vitamin-D deficiency and sufficiency
In early 2000’s vitamin-D deficiency was shown to be prevalent in several countries including the United States (US).
Original paper ↗Read more →Vitamin D Toxicity-A Clinical Perspective
Confusion, apathy, recurrent vomiting, abdominal pain, polyuria, polydipsia, and dehydration are the most often noted clinical symptoms of vitamin D toxicity (VDT; also called vitamin D intoxication or hypervitaminosis D).
Original paper ↗Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Effect of dietary Ca:P ratio on ionized calcium and calcium homeostasis in cats with early-stage chronic kidney disease
The aim of the study was to compare two renal foods with different Ca:P ratios on manifestation of hypercalcemia and regulation of calcium homeostasis in cats with chronic kidney disease (CKD).
Original paper ↗Read more →Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study
This study aimed to determine the prevalence of hypovitaminosis D in Nepalese RTRs and interrelations between serum 25-hydroxyvitamin D [25(OH) D] and other biochemical parameters.
Original paper ↗Read more →The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis: clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD.
Original paper ↗Read more →Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function
Plasma approaches metastability with respect to its calcium and phosphate content, with only minor perturbations in ionic activity needed to sustain crystal growth once nucleated.
Original paper ↗Read more →Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Full Study
AA full evidence review of how excess vitamin D activity, extrarenal calcitriol production and impaired CYP24A1 clearance can cause hypercalcaemia.
Read more →Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Study Summary
A concise evidence summary of how vitamin D excess, excessive calcitriol production and impaired degradation can cause hypercalcaemia.
Read more →A Rare Presentation of Renal Sarcoidosis with Severe, Recurrent Hypercalcemia Despite Low-normal Vitamin D Levels
We describe a diagnostically challenging case of a 56-year-old female with goblet cell adenocarcinoma of the appendix, evaluated for acute kidney injury (AKI) and hypercalcemia after abnormal labs at a routine oncology visit.
Original paper ↗Read more →Hypercalcemia and acute kidney injury caused by occupational inhalation of vitamin D3: a case report
Vitamin D intoxication is a rare but potentially life-threatening condition that can lead to severe hypercalcemia and serious complications.
Original paper ↗Read more →Hypercalcemia Associated with Calcium Supplement Use: Prevalence and Characteristics in Hospitalized Patients
Objectives: To evaluate the prevalence and characteristics of hypercalcemia induced by calcium intake (“calcium supplement syndrome”; or CSS) in hospitalized patients.
Original paper ↗Read more →Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients
Febrile dyspnea was less frequent in hypercalcemic PJP-patients compared to non-hypercalcemic (29 versus 67%).
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Clinical and molecular correlation defines activity of physiological pathways in life-sustaining kidney xenotransplantation
Porcine kidney xenotransplantation is accelerating towards clinical translation.
Original paper ↗Read more →Eldecalcitol and calcium supplementation in Chinese women with postmenopausal osteoporosis: a prospective observational cohort study
Hypercalcemia incidence was higher in patients with compared to without calcium supplementation, indicating that concomitant eldecalcitol and calcium should be carefully considered.
Original paper ↗Read more →Impact of Calcium-Magnesium Ratio in Purified Water Remineralization on Calcium Oxalate Crystal Formation and Renal Injury
Objectives: This study investigates the impact of different Ca:Mg in the remineralization of purified water on calcium oxalate crystallization and renal injury.
Original paper ↗Read more →Klotho in the kidney distal convolution regulates urinary Klotho excretion and kidney calcium reabsorption, but not phosphate homeostasis
Klotho acts as a coreceptor for the phosphaturic hormone fibroblast growth factor-23 (FGF-23) and exists in both a membrane-bound and a soluble form (sKlotho) found in blood and urine.
Original paper ↗Read more →Persistent changes in calcium-regulating hormones and bone turnover markers in living kidney donors more than 20 years after donation
In our recent survey-based study, we found no increased risk of fractures of all types but observed significantly more vertebral fractures in LKDs compared with matched controls.
Original paper ↗Read more →Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)
This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants.
Original paper ↗Read more →The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss: a case report
Demineralisation and bone density loss during immobilisation are known phenomena.
Original paper ↗Read more →Original sources
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Published in Endocrine Reviews (2016).
Publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521 to 547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Vitamin D Toxicity-A Clinical Perspective
Confusion, apathy, recurrent vomiting, abdominal pain, polyuria, polydipsia, and dehydration are the most often noted clinical symptoms of vitamin D toxicity (VDT; also called vitamin D intoxication or hypervitaminosis D).
Publication details
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity-A Clinical Perspective. Frontiers in Endocrinology. 2018;9:550. PMID: 30294301. PMCID: PMC6158375. DOI: 10.3389/fendo.2018.00550.
Cytochrome P450-mediated metabolism of vitamin D
Published in Journal of Lipid Research (2014).
Publication details
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13 to 31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.